Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma

Ahmad A. Tarhini, Alyssa Obermayer, Sandra J. Lee, William A. LaFramboise, F. Stephen Hodi, Arivarasan D. Karunamurthy, Islam Eljilany, Dung-Tsa Chen, Patrick Hwu, Issam M. El Naqa, Howard Streicher, Vernon K. Sondak, Walter J. Storkus, Lisa H. Butterfield, Timothy I. Shaw, John M. Kirkwood

Open source

DOI: 10.1158/1078-0432.ccr-24-3980
Published: 2025-05-20
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-3980,
  title = {Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma},
  author = {Ahmad A. Tarhini and Alyssa Obermayer and Sandra J. Lee and William A. LaFramboise and F. Stephen Hodi and Arivarasan D. Karunamurthy and Islam Eljilany and Dung-Tsa Chen and Patrick Hwu and Issam M. El Naqa and Howard Streicher and Vernon K. Sondak and Walter J. Storkus and Lisa H. Butterfield and Timothy I. Shaw and John M. Kirkwood},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-3980},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-3980}
}

RIS

TY  - JOUR
TI  - Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma
AU  - Ahmad A. Tarhini
AU  - Alyssa Obermayer
AU  - Sandra J. Lee
AU  - William A. LaFramboise
AU  - F. Stephen Hodi
AU  - Arivarasan D. Karunamurthy
AU  - Islam Eljilany
AU  - Dung-Tsa Chen
AU  - Patrick Hwu
AU  - Issam M. El Naqa
AU  - Howard Streicher
AU  - Vernon K. Sondak
AU  - Walter J. Storkus
AU  - Lisa H. Butterfield
AU  - Timothy I. Shaw
AU  - John M. Kirkwood
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-3980
UR  - https://doi.org/10.1158/1078-0432.ccr-24-3980
ER  -

APA

Tarhini, A. A., Obermayer, A., Lee, S. J., LaFramboise, W. A., Hodi, F. S., Karunamurthy, A. D., Eljilany, I., Chen, D., Hwu, P., Naqa, I. M. E., Streicher, H., Sondak, V. K., Storkus, W. J., Butterfield, L. H., Shaw, T. I., & Kirkwood, J. M. (2025). Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3980

Source records

crossref · retrieved 2026-09-26T21:25:27.998Z